Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Eucalyptus Oil Market 2021 Key Traits, Functions & Future Developments, specializing in prime key...
The latest research on Global Eucalyptus Oil Market was conducted in a variety of industries in different regions to provide a report with...